02 May 2003
Poly(ADP-ribose) polymerase-1 inhibitors and protection of post-ischemic neuronal damage
F. Moroni, A. Cozzi, E. Meli, A. Chiarugi, M. Pangallo, D. Pellegrini-GiampietroMed Sci Monit 2003; 9(1): 45-0 :: ID: 15108
Abstract
We studied the effects of several PARP inhibitors (including 3, 4-dihydro-5-[4-(1-piperidinyl)butoxyl]-1(2H)-isoquinolinone (DPQ), thieno [2,3-C]-isoquinolinon-5-one (TIQ-A) and others) against oxygen plus glucose deprivation (OGD)-induced neuronal death in primary cultures of i) mixed murine cortical cells or ii) organotypic rat hippocampal slices. We also evaluated the neuroprotective effects of systemic administration of PARP inhibitors after iii) transient or iv) permanent occlusion of the middle cerebral artery (MCA) in rats or v) after transient bilateral carotid occlusion in gerbils.Cortical cells exposed to OGD released lactate dehydrogenase into the medium and displayed ultrastructural features of necrotic cell death, with neither caspase-3 activation nor morphological features of apoptosis at any time point after OGD. In contrast, in the CA1 subregion of organotypic hippocampal slices, OGD caused apoptotic neuronal death (evaluated using fluorescence and electron microscopic approaches) and a marked increase in caspase-3 activity. PARP-inhibitors (DPQ, TIQ-A and others) reduced neuronal death in mixed cortical cells but not in organotypic slice cultures.The administration of TIQ-A (3 and 10 mg/Kg, i.p.) and DPQ (10 mg/Kg, i.p.) reduced the infarct volume caused by transient (2h) MCA occlusion in rats. TIQ-A (but not DPQ) significantly reduced the infarct volume also when administered after permanent MCAO. PARP inhibitors were unable to reduce CA1 hippocampal pyramidal cell loss in gerbils exposed to transient (5 min) forebrain ischemia.Our results show that TIQ-A, a novel and potent PARP-1 inhibitor, may have neuroprotective effects against focal but not global forebrain ischemia. References: 1.Moroni F, Meli E, Peruginelli F, Chiarugi A et al: Poly(ADP-ribose) polymerase inhibitors attenuate necrotic but not apoptotic neuronal death in experimental models of cerebral ischemia. Cell Death Differ, 2001; 8: 921-932 2.Chiarugi A, Meli E, Picca R et al: Novel isoquinolinone-derived inhibitors of poly(ADP-ribose) polymerase-1: pharmacological characterization and neuroprotective effects in an in vitro model of cerebral ischemia. Submitted to JPET
Keywords: Brain Ischemia, Stroke, TIQ-A, DPQ
Editorial
01 April 2025 : Editorial
Editorial: Rapid Testing for the Avian Influenza A(H5N1) Virus is Urgently Required as Infections in Poultry and Dairy Cows are on the Rise, and so is Transmission to HumansDOI: 10.12659/MSM.949109
Med Sci Monit 2025; 31:e949109
In Press
Clinical Research
Impact of Depression, Fatigue, and Pain on Quality of Life in Slovak Multiple Sclerosis PatientsMed Sci Monit In Press; DOI: 10.12659/MSM.947630
Clinical Research
Longitudinal Evaluation of Metabolic Benefits of Inactivated COVID-19 Vaccination in Diabetic Patients in T...Med Sci Monit In Press; DOI: 10.12659/MSM.947450
Clinical Research
Impact of Voltage Level on Hospitalization and Mortality in Electrical Injury Cases: A Retrospective Analys...Med Sci Monit In Press; DOI: 10.12659/MSM.947675
Clinical Research
Comparative Study of Plantar Load and Foot Posture Characteristics in Male Elite Squash Players and Non-Ath...Med Sci Monit In Press; DOI: 10.12659/MSM.947828
Most Viewed Current Articles
17 Jan 2024 : Review article 8,044,083
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research 702,972
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Mar 2024 : Editorial 30,118
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...DOI :10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
28 Jan 2024 : Review article 24,024
A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and FutureDOI :10.12659/MSM.943912
Med Sci Monit 2024; 30:e943912